John Brottem Buys Shares of OM $OM

Key Points

  • John Brottem bought 59,830 shares of Outset Medical, Inc. ($OM).
  • $OM last traded around $4.33.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

John Brottem, General Counsel at Outset Medical, Inc. ($OM), bought 59,830 shares at an average price of $0. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Outset Medical, Inc. Stock Up 9.9%

Shares of Outset Medical, Inc. ($OM) traded around $4.33 on Tuesday, up 9.9% for the day.

Last price$4.33
Market cap$71.81M
Forward P/E-1.67
Beta1.92
52-week low$3
52-week high$16.16
50-day MA$4.50
200-day MA$4.29
Current ratio5.19
Quick ratio4.02
Debt-to-equity1.08

Outset Medical, Inc. Earnings

EPS (ttm)-$3.80
Revenue (ttm)$117.80M
Revenue growth0.70%
Net margin-63.06%
Return on equity-59.17%
Next earningsNov 9, 2026

Analysts Set New Price Targets

Average target$7.67
High target$10
Low target$6
Analysts covering3

About Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

ExchangeNasdaqGS
SectorHealthcare
IndustryMedical Devices
HeadquartersSan Jose, CA
CEOMs. Leslie L. Trigg
Employees310

Get Outset Medical, Inc. alerts

New 13F filings, insider trades, and analyst moves on $OM, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.